Annual Securities Report — FY2025
What Daito Pharmaceutical Co.,Ltd. reported for the period from 2025-06-01 to 2026-05-31.
Filed 2026-08-26View the original on EDINET
How much it says
75Very detailed
What moved here
27named for the first time
Its own wording
54terms
Which filing this is
36/ 36newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
Under the Daito Transformation Plan 2027, the filing describes progress in the business centered on APIs and finished pharmaceuticals, consolidated results reflecting investment in the Second Testing Building and Tenth Finished-Pharmaceutical Building, and shareholder returns through share repurchases, cancellations, and dividends. New strategic and organizational initiatives include human capital measures such as the planned introduction of an elective defined-contribution pension plan and the establishment of the Sustainability Committee.
Komori's summary of this document, not the document's own words.75Very detailed
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 34 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
68
Detailed
100
Very detailed
75
Very detailed
100
Very detailed
68
Detailed
69
Detailed
53
Typical
55
Typical
73
Detailed
R&D spend22億円Money spent making new things.
Cash left over50億円Cash from the business, less what went into equipment.
Spent on equipment46億円Plants, machines — things meant to last.
Employees987Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.